Le Lézard
Classified in: Health
Subjects: CCA, ACC

Capio to Publish Full Year Report on February 7, 2018


GÖTEBORG, Sweden, Jan. 17, 2018 /PRNewswire/ --

Capio AB will publish the Full year report for January-December 2017 on Wednesday, February 7 at approximately 08.00 am (CET)

08.00 am (approximately)
Report release. The report will be sent as a press release and will be published on Capio's website www.capio.com.

09.30 am Telephone conference and audio cast
Investors, analysts and media are invited to participate in a telephone conference at 09.30 am (CET).

President and CEO Thomas Berglund and CFO Olof Bengtsson will present the report and answer questions (in English).

The telephone conference will be audio casted live on www.capio.com.

To participate in the telephone conference, please register at www.capio.com and dial in five minutes prior to the start of the conference call.

Sweden: +46 8 566 426 93
UK: +44 20 3008 9804
US: +1 855 753 2237
Finland: +35 898 171 04 93
France: +33 170 75 07 12

Prior to the start of the telephone conference, presentation slides will be available at www.capio.com.

A recorded version of the audio cast will be made available at www.capio.com during the afternoon (CET).

Subscribe to press releases and financial information
To receive press releases and financial reports from Capio, please subscribe at www.capio.com/subscribe.

For information, please contact:

Olof Bengtsson, CFO
Telephone: +46-761-18-74-69

Kristina Ekeblad, IR manager
Telephone: +46-708-31-19-40

This information was brought to you by Cision http://news.cision.com
http://news.cision.com/capio-ab/r/capio-to-publish-full-year-report-on-february-7--2018,c2432186

The following files are available for download:

http://mb.cision.com/Main/277/2432186/778077.pdf

PDF

 


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: